HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wu, M. H. Articles by Dolan, M. E. Search for Related Content PubMed PubMed Citation Articles by Wu, M. H. Articles by Dolan, M. E.

High Efficiency Electroporation of Human Umbilical Cord Blood CD34⁺ Hematopoietic Precursor Cells

^a Section of Hematology-Oncology, Department of Medicine and Cancer Research Center, Committee on Cancer Biology, University of Chicago, Chicago, Illinois USA;
^b Present address: Institute for Transfusion Medicine, Clinical Services-Stem Cell Department, Glenview, Ilinois, USA

Key Words. Electroporation • Hematopoietic • Cord blood plasma

M. Eileen Dolan, Ph.D., Section of Hematology-Oncology, University of Chicago, 5841 S. Maryland Ave., Box MC2115, Chicago, Illinois 60637, USA. Telephone: 773-702-4441; Fax 773-702-0963; e-mail: edolan{at}medicine.bsd.uchicago.edu

Human umbilical cord blood provides an alternative source of hematopoietic cells for purposes of transplantation or ex vivo genetic modification. The objective of this study was to evaluate electroporation as a means to introduce foreign genes into human cord blood CD34⁺ cells and evaluate gene expression in CD34⁺/CD38^dim and committed myeloid progenitors (CD33⁺, CD11b⁺). CD34⁺ cells were cultured in X-VIVO 10 supplemented with thrombopoietin, stem cell factor, and Flt-3 ligand. Electroporation efficiency and cell viability measured by flow cytometry using enhanced green fluorescent protein (EGFP) as a reporter indicated 31% ± 2% EGFP⁺/CD34⁺ efficiency and 77% ± 3% viability as determined 48 hours post-electroporation. The addition of allogeneic cord blood plasma increased the efficiency to 44% ± 5% with no effect on viability. Of the total CD34⁺ cells 48 hours post-electroporation, 20% were CD38^dim/EGFP⁺. CD34⁺ cells exposed to interleukin-3, GM-CSF and G-CSF for an additional 11 days differentiated into CD33⁺ and CD11b⁺ cells, and 9% ± 3% and 8% ± 7% were expressing the reporter gene, respectively. We show that electroporation can be used to introduce foreign genes into early hematopoietic stem cells (CD34⁺/CD38^dim), and that the introduced gene is functionally expressed following expansion into committed myeloid progenitors (CD33⁺, CD11b⁺) in response to corresponding cytokines. Further investigation is needed to determine the transgene expression in functional terminal cells derived from the genetically modified CD34⁺ cells, such as T cells and dendritic cells.

This article has been cited by other articles:

				Q. Wang, Z. Huang, H. Xue, C. Jin, X.-L. Ju, J.-D. J. Han, and Y.-G. Chen MicroRNA miR-24 inhibits erythropoiesis by targeting activin type I receptor ALK4 Blood, January 15, 2008; 111(2): 588 - 595. [Abstract] [Full Text] [PDF]

				Z. Jin, M. Ran, and Z. Man Arsenic trioxide entered cerebrospinal fluid with the help of mannitol overwhelm the meningeal relapse of acute promyelocytic leukemia Haematologica, September 1, 2007; 92(9): e82 - e84. [Full Text] [PDF]

				S. Akagi, H. Ichikawa, T. Okada, A. Sarai, T. Sugimoto, H. Morimoto, T. Kihara, A. Yano, K. Nakao, Y. Nagake, et al. The Critical Role of Src Homology Domain 2-Containing Tyrosine Phosphatase-1 in Recombinant Human Erythropoietin Hyporesponsive Anemia in Chronic Hemodialysis Patients J. Am. Soc. Nephrol., December 1, 2004; 15(12): 3215 - 3224. [Abstract] [Full Text] [PDF]